Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Common Stock · CUSIP: 29664W105

Event date: 2025-03-31

Filing-level shares
10,931,257.00
Percent of class
5.5%
  • WASATCH ADVISORS LP

    Shares: 10,931,257.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000814133-25-000031
Form type
SCHEDULE 13G/A
Filer
Esperion Therapeutics, Inc.
CIK
CIK 1434868
Filed
Apr 07, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub